Non-Langerhans cell histiocytosis

From WikiMD.org
Jump to navigation Jump to search

Non-Langerhans cell histiocytosis (pronunciation: non-LAN-ger-hanz cell his-tee-oh-sigh-TOE-sis) is a rare type of histiocytosis, a group of diseases that involve an abnormal increase in the number of immune cells known as histiocytes. This condition is characterized by the accumulation of histiocytes that do not originate from the Langerhans cells, a type of dendritic cell that normally helps the body fight off infections.

Etymology

The term "Non-Langerhans cell histiocytosis" is derived from the name of the German physician Paul Langerhans, who first described the Langerhans cells, and the Greek words "histio" (tissue) and "cytosis" (condition of cells), indicating an abnormal condition of tissue cells.

Types

Non-Langerhans cell histiocytosis can be classified into several types, including:

Each type is characterized by different symptoms, causes, and treatment options.

Symptoms

The symptoms of Non-Langerhans cell histiocytosis can vary widely depending on the type and the organs affected. Common symptoms may include skin lesions, bone pain, and organ dysfunction.

Diagnosis

Diagnosis of Non-Langerhans cell histiocytosis typically involves a combination of physical examination, medical history, and laboratory tests. A biopsy of the affected tissue is often necessary to confirm the diagnosis.

Treatment

Treatment for Non-Langerhans cell histiocytosis depends on the type and severity of the disease. It may include surgery, radiation therapy, chemotherapy, or targeted therapies.

See also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski